Influence of vitamin D supplementation and the vaginal microenvironment on human papillomavirus infection

Caiyan Xu, Jun Liu

Abstract

This was a retrospective study, mainly explored the mediating role of vaginal microenvironment and the influence of vitamin D addition on human papillomavirus (HPV) infection. Five hundred and twelve participants were chosen in this study, followed by dividing into HPV positive (212 cases) and negative groups (300 cases) based on HPV 23 typing results. The high-risk human papillomavirus (HR-HPV) positive group showed higher abnormal rates of lactobacillus, catalase, cleanliness, sialidosidase, and proline aminopeptidase than the HPV negative group. No significant differences were found in pH value, leukocyte esterase, and Acetylglucosaminidase abnormality between 2 groups. The HR-HPV positive group presented a higher percentage of patients with cleanliness III and IV. Relative to low-grade squamous intraepithelial lesion (LSIL) group, HSIL group presented a higher HPV positive infection rate. Mould infection, Gardnerella infection, and catalase were identified as independent risk elements for HRHPV infection. Vitamin D supplementation was found to potentially reduce HR-HPV infection persistence post-Loop Electrosurgical Excision Procedure (LEEP), improve nutritional health, reduce insulin, insulin resistance (HOMA-IR) and triglyceride levels, as well as reduce high-sensitivity C-reactive protein (hs-CRP) along with malondialdehyde (MDA) levels. Our results indicate that HR-HPV infection is intimately associated with the condition of the vaginal microenvironment, and vitamin D addition potentially reduces the persistence of HR-HPV infection post-LEEP, improves nutritional and metabolic health, reduces inflammation, and be well-tolerated.

Full Text:

PDF

References

Thun MJ, DeLancey JO, Center MM, Jemal A and Ward EM.

The global burden of cancer: priorities for prevention.

Carcinogenesis. 2010; 31(1):100-10.

Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal

A, Yu XQ and He J. Cancer statistics in China, 2015.

CA Cancer J Clin. 2016; 66(2):115-32.

Wright TC, Jr., Cox JT, Massad LS, Carlson J, Twiggs LB

and Wilkinson EJ. 2001 consensus guidelines for the

management of women with cervical intraepithelial

neoplasia. Am J Obstet Gynecol. 2003; 189(1):295-

Chao X, Sun T, Wang S, Tan X, Fan Q, Shi H, Zhu L and

Lang J. Research of the potential biomarkers in

vaginal microbiome for persistent high-risk human

papillomavirus infection. Ann Transl Med. 2020;

(4):100.

Mitra A, MacIntyre DA, Marchesi JR, Lee YS, Bennett PR

and Kyrgiou M. The vaginal microbiota, human

papillomavirus infection and cervical intraepithelial

neoplasia: what do we know and where are we going

next? Microbiome. 2016; 4(1):58.

Przybylski M, Pruski D, Millert-Kalinska S, Zmaczynski A,

Baran R, Horbaczewska A, Jach R and Zaborowska L.Remission of HPV infection after LEEP-conization -

a retrospective study. Ginekol Pol. 2022;

Petrillo M, Dessole M, Tinacci E, Saderi L, Muresu N,

Capobianco G, Cossu A, Dessole S, Sotgiu G and

Piana A. Efficacy of HPV Vaccination in Women

Receiving LEEP for Cervical Dysplasia: A Single

Institution's Experience. Vaccines (Basel). 2020; 8(1)

Aryanian Z, Balighi K, Goodarzi A, Afshar ZM, Hatami P.

Vitamin D and HPV infection: Clinical pearls. J

Cosmet Dermatol. 2024;

Chu TW, Jhao JY, Lin TJ, Lin TW, Wang CL, Chang HS, Liu

LC and Chang CC. Vitamin D in gynecological

diseases. J Chin Med Assoc. 2021; 84(11):1054-1059.

Wilson Westmark NL, Sroussi H, Tamayo I and Villa A.

Vitamin D status in patients with oropharyngeal

cancer: Association with HPV status and prognosis.

Oral Dis. 2023; 29(2):542-546.

Brestovac B, Wong ME, Costantino PS and Groth D. A rapid

DNA extraction method suitable for human

papillomavirus detection. J Med Virol. 2014;

(4):653-7.

Smith JH. Bethesda 2001. Cytopathology : official journal

of the British Society for Clinical Cytology. 2002;

(1):4-10.

Ndizeye Z, Menon S, Van Geertruyden JP, Sauvaget C,

Jacquemyn Y, Bogers JP, Benoy I and Vanden Broeck

D. Performance of OncoE6(TM) Cervical Test in

detecting cervical precancer lesions in HIV-positive

women attending an HIV clinic in Bujumbura,

Burundi: a cross-sectional study. BMJ Open. 2019;

(9):e029088.

Tabassi Z, Bagheri S, Samimi M, Gilasi HR, Bahmani F,

Chamani M and Asemi Z. Clinical and Metabolic

Response to Vitamin D Supplementation in

Endometrial Hyperplasia: a Randomized, DoubleBlind, Placebo-Controlled Trial. Horm Cancer. 2017;

(3):185-195.

Razzaghi R, Pourbagheri H, Momen-Heravi M, Bahmani F,

Shadi J, Soleimani Z and Asemi Z. The effects of

vitamin D supplementation on wound healing and

metabolic status in patients with diabetic foot ulcer: A

randomized, double-blind, placebo-controlled trial. J

Diabetes Complications. 2017; 31(4):766-772.

Weston G, Dombrowski C, Harvey MJ, Iftner T, Kyrgiou M,

Founta C and Adams EJ. Use of the Aptima mRNA

high-risk human papillomavirus (HR-HPV) assay

compared to a DNA HR-HPV assay in the English

cervical screening programme: a decision tree model

based economic evaluation. BMJ Open. 2020;

(3):e031303.

Vos RA, Pasmans H, Tymchenko L, Janga-Jansen AVA,

Baboe-Kalpoe S, Hulshof K, de Melker HE and van

der Klis FRM. High seroprevalence of multiple highrisk human papillomavirus types among the general

population of Bonaire, St. Eustatius and Saba,

Caribbean Netherlands. Vaccine. 2020; 38(13):2816-

Castle PE, Varallo JE, Bertram MM, Ratshaa B, Kitheka M

and Rammipi K. High-risk human papillomavirus

prevalence in self-collected cervicovaginal specimens

from human immunodeficiency virus (HIV)-negative

women and women living with HIV living in

Botswana. PLoS One. 2020; 15(2):e0229086.

Pańczyszyn A, Boniewska-Bernacka E and Głąb G.

Telomere length in leukocytes and cervical smears of

women with high-risk human papillomavirus (HR

HPV) infection. Taiwan J Obstet Gynecol. 2020;

(1):51-55.

Manley KM, Luker R and Park C. An audit of liquid-based

cytology samples reported as high-risk human

papillomavirus and borderline nuclear change in

endocervical cells. Cytopathology. 2020; 31(2):130-

Sangpichai S, Patarapadungkit N, Pientong C,

Ekalaksananan T, Chaiwiriyakul S, Thongbor R,

Sirivech P, Jangsiriwitayakorn P and

Triamwittayanon T. Chlamydia Trachomatis

Infection in High-Risk Human Papillomavirus Based

on Cervical Cytology Specimen. Asian Pac J Cancer

Prev. 2019; 20(12):3843-3847.

Zhao S, Zhao XL, Hu SY, Wang Y, Remila R, Xu XQ, Duan

XZ, Chen F, Zhang X and Zhao FH. [Comparison of

high-risk human papillomavirus infection rate and

genotype distribution between Han and Mongolian

women]. Zhonghua Liu Xing Bing Xue Za Zhi. 2019;

(11):1439-1444.

Cao M, Wang Y, Wang D, Duan Y, Hong W, Zhang N, Shah

W, Wang Y and Chen H. Increased High-Risk Human

Papillomavirus Viral Load Is Associated With

Immunosuppressed Microenvironment and Predicts a

Worse Long-Term Survival in Cervical Cancer

Patients. Am J Clin Pathol. 2020; 153(4):502-512.

Kang HJ, Chu KB, Kim MJ, Park H, Jin H, Lee SH, Moon

EK and Quan FS. Evaluation of CpG-ODNAdjuvanted Toxoplasma Gondii Virus-Like Particle

Vaccine upon One, Two, and Three Immunizations.

Pharmaceutics. 2020; 12(10)

Nikouyan N, Farhadi A, Gorzin AA, Geramizadeh B,

Okhovat MA, Seyyedi N, Dehbidi GR, Ranjbaran R

and Behzad-Behbahani A. A fluorometric

hybridization assay for detecting and genotyping

high-risk human papillomavirus 16 and 18 in archival

tissues of cervical specimens. Braz J Microbiol. 2020;

(1):161-168.

Chan PK, Cheung TH, Li WH, Yu MY, Chan MY, Yim SF,

Ho WC, Yeung AC, Ho KM and Ng HK. Attribution

of human papillomavirus types to cervical

intraepithelial neoplasia and invasive cancers in

Southern China. Int J Cancer. 2012; 131(3):692-705.

Kyrgiou M, Mitra A and Moscicki AB. Does the vaginal

microbiota play a role in the development of cervical

cancer? Transl Res. 2017; 179:168-182.

Troja C, Hoofnagle AN, Szpiro A, Stern JE, Lin J and Winer

RL. Understanding the Role of Emerging Vitamin D

Biomarkers on Short-term Persistence of High-Risk

Human Papillomavirus Infection Among Mid-Adult

Women. J Infect Dis. 2021; 224(1):123-132.

Brewczyński A, Jabłońska B, Mrowiec S, Składowski K and

Rutkowski T. Nutritional Support in Head and Neck

Radiotherapy Patients Considering HPV Status.

Nutrients. 2020; 13(1)

Saroul N, Martraix C, Mulliez A, Cassagnes L, Puechmaille

M, Bernadach M, Biau J, Walrand S and Lapeyre M.

[Impact of HPV status on nutritional status during

radio chemotherapy for oropharyngeal cancer].

Cancer Radiother. 2023; 27(1):42-49.

Sutandyo N, Brahma B and Ifandriani R. Pretreatment

nutritional status, HPV infection, and tumor

infiltrating lymphocyte as prognostic predictors in

patients with head and neck squamous cell carcinoma

after chemotherapy. J Cancer Res Ther. 2022;

(Supplement):S177-s181.

Lee DY and Lee TS. Associations between metabolic

syndrome and gynecologic cancer. Obstet Gynecol

Sci. 2020; 63(3):215-224.

Zhou Z-W, Long H-Z, Cheng Y, Luo H-Y, Wen D-D and

Gao L-C. From Microbiome to Inflammation: The

Key Drivers of Cervical Cancer. Frontiers in

Microbiology. 2021; 12

Refbacks

  • There are currently no refbacks.